Table 2.
Causes of Death | |||
---|---|---|---|
Multiorgan Failure (MF) (N = 29) |
Sepsis (S) (N = 39) |
Graft Failure (GF) (N = 32) |
|
KIR Genes | n (%) | n (%) | n (%) |
iKIRs | |||
KIR2DL1+/S1− | 19 (65.5) | 23 (58.9) | 22 (68.7) |
KIR2DL2+ | 22 (75.8) a | 21 (53.8) | 14 (43.7) |
KIR2DL3+ | 26 (89.6) | 36 (92.3) | 30 (93.7) |
KIR3DL1+ | 24 (82.7) | 31 (79.4) | 30 (93.7) |
aKIRs | |||
KIR2DS1+ | 11 (37.9) | 13 (33.3) | 10 (31.2) |
KIR2DS2+ | 22 (75.8) b | 20 (51.2) c | 14 (43.7) |
KIR2DS3+ | 9 (31.0) | 7 (17.9) | 10 (31.2) |
KIR2DS4+ | 24 (82.7) | 31 (79.4) | 30 (93.7) |
KIR2DS5+ | 11 (37.9) | 12 (30.7) | 10 (31.2) |
N is the total number of individuals; n is the number of individuals with a KIR gene. MF; Multiorgan failure; S; Sepsis, GF; Graft failure. All comparisons were made using the 2-tailed Fisher’s exact test. a OR = 0.247; 95% CI: 0.082–0.744, p = 0.018; p value obtained by comparing MF KIR2DL2+ patients with GF KIR2DL2+ patients. b OR =2.986; 95% CI: 1.037–8.594, p = 0.047; p value obtained by comparing MF KIR2DS2+ patients with GF KIR2DS2+ patients. c OR = 4.041; 95% CI: 1.344–12.146, p = 0.018; p value obtained by comparing MF KIR2DS2+ patients with GF KIR2DS2+ patients.